$ECTE staging upchannel $2.07 Nasdaq CM Websi

$ECTE staging upchannel $2.07
Nasdaq CM

Website

Echo Therapeutics, Inc. is engaged in the development of transdermal skin
permeation and diagnostic medical devices. It is developing Symphony
CGM system (Symphony), a needle-free wireless continuous glucose
monitoring system for use in hospital critical care units; and Symphony
SkinPrep system, a component of its Symphony for enhanced skin
permeation that enables extraction of analytes, such as glucose.

72 % Buy Detailed Opinion


Shares Outstanding: 12.63M
Float: 9.29M
% Held by Insiders: 20.59%
% Held by Institutions: 7.10%
Shares Short (as of Dec 31, 2014): 369.66K
Short Ratio (as of Dec 31, 2014): 3.00
Short % of Float (as of Dec 31, 2014): 3.80%
Shares Short (prior month): 260.92K



10-Q 11/9/14
Summary

Recent Trades


Headlines

Thursday, January 22, 2015
Echo Therapeutics Restores Pact with MTIA, Issues Patent - Analyst BlogZacks (Thu, Jan 22)

Wednesday, January 21, 2015
Echo Therapeutics and Medical Technologies Innovation Asia (MTIA) Re-affirm Operational PartnershipPR Newswire (Wed, Jan 21)

Tuesday, January 6, 2015
ECHO THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Tue, Jan 6)
Echo Therapeutics Re-hires Key Product Development Team In Support of New Corporate StrategyPR Newswire (Tue, Jan 6)

Friday, January 2, 2015
CFO Moves: Echo Therapeutics, ADVA, Tanzanian Royalty Exploration, Westaim, Ansal Propertiesat The Wall Street Journal (Fri, Jan 2)

Tuesday, December 30, 2014
ECHO THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or PrinciEDGAR Online (Tue, Dec 30)
Echo Therapeutics Appoints Alan W. Schoenbart as Chief Financial OfficerPR Newswire (Tue, Dec 30)

Tuesday, December 23, 2014
Echo Therapeutics Announces Scott W. Hollander as President & Chief Executive OfficerPR Newswire (Tue, Dec 23)

Friday, December 19, 2014
ECHO THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity SEDGAR Online (Fri, Dec 19)

Friday, December 12, 2014
ECHO THERAPEUTICS, INC. Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Statements and EEDGAR Online (Fri, Dec 12)

Thursday, November 27, 2014
ECHO THERAPEUTICS, INC. FinancialsEDGAR Online Financials (Thu, Nov 27)

Wednesday, November 26, 2014
ECHO THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal OfficersEDGAR Online (Wed, Nov 26)

Saturday, November 22, 2014
10-Q/A for Echo Therapeutics, Inc.Company Spotlight (Sat, Nov 22)
Friday, November 21, 2014
10-Q for Echo Therapeutics, Inc.Company Spotlight (Fri, Nov 21)

Thursday, November 20, 2014
ECHO THERAPEUTICS, INC. Files SEC form 10-Q/A, Quarterly ReportEDGAR Online (Thu, Nov 20)

Wednesday, November 19, 2014
Echo Therapeutics Announces Third Quarter 2014 Financial ResultsPR Newswire (Wed, Nov 19)
ECHO THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online (Wed, Nov 19)

Friday, November 7, 2014
ECHO THERAPEUTICS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or StaEDGAR Online (Fri, Nov 7)

Monday, November 3, 2014
ECHO THERAPEUTICS, INC. Files SEC form 8-K, Termination of a Material Definitive AgreementEDGAR Online (Mon, Nov 3)
Echo Therapeutics to Present Positive Clinical Trial Results at the 14th Annual Diabetes Technology MeetingPR Newswire (Mon, Nov 3)

Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP